abiraterone,olaparib
astrazeneca,janssen,merck
['abira', 'abiraterone', 'biomarker', 'propel', 'olaparib', 'brca', 'marker ']
biomarker analysis and updated results from the phase ill propel. by dr. f saad pfs benefit was observed with abiraterone + olaparib regardless of hrrm but more clear in brcam but no os benefit yet! #esmo22 
Pursuing to improve cancer prevention and care. Medical Oncologist @AnkaraUni